Title: Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia (REVIVE)

Experimental stem cell therapy for swallowing disorders resulting from treatment for head and neck cancer.

ClinicalTrials.Gov Identifier: NCT05421689, UC Davis IRB#1851097

Description of the Clinical Trial: To compare the potential benefits of muscle stem cells injected into the tongue in subjects with moderate swallowing difficulty from head and neck cancer treatment to placebo. This is a double-blind, randomized, placebo-controlled Phase II clinical trial.

Principal Investigator: Peter Belafsky, M.D., M.P.H., Ph.D., Department of Otolaryngology

Study Website: https://studypages.com/s/stem-cell-clinical-trial-for-swallowing-disorders-revive-460666/

Study In-Take Questionnaire: https://ucdavis.co1.qualtrics.com/jfe/form/SV_4O9WMsjw9EKto6q

For questions about this clinical trial, please email: HS-ENTStemCell@ucdavis.edu.

Research Coordinator: Angela Beliveau, UC Davis Department of Otolaryngology.

Title: Registry of Subject Treated With ClariFix

ClinicalTrials.gov Identifier: NCT03739216 / UC Davis IRB# 1317894

Description of Research Study: A multi-center, prospective, non-randomized, observational registry to assess the results of the ClariFix(TM) device when used to ablate unwanted tissue in the nose of subjects with chronic rhinitis

Principal Investigator: Toby O. Steele, M.D., Department of Otolaryngology

Co-Investigators: Brad Strong, M.D., Lane Squires, M.D., Department of Otolaryngology

Research Coordinator: Randev Sandhu, UC Davis Department of Otolaryngology, 916-734-2863, rssandhu@ucdavis.edu

Research joint email address: HS-OTO Study hs-oto-study@ou.ad3.ucdavis.edu